Par Syndicate EIS Fund
These days investors are overwhelmed with brilliant new ideas promising to be the next big thing. A start-up destined to be the next Facebook; a gadget touting itself as the new iPod; a drug promising to change the face of medicine. The skill lies in selecting investments with the potential to unlock commercial opportunities, not just big ideas.
That’s where Par Equity, the managers of the Par Syndicate EIS Fund, believe they can help. They aim to marry innovation with commercial opportunity. The fund invests in innovative SMEs with high growth potential, alongside seasoned entrepreneurs. They invest in what they call the “equity gap”. This is the area beyond the reach of most business angels but not quite big enough for private equity to be interested.
Par Equity has a relatively cautious approach to these early-stage technology businesses, although the fund remains a high-risk, high potential return investment. The fund steers clear of companies with over-egged valuations favouring those with defensible intellectual property, a proven track record of sales and a positive response from early adopters or consumers.
- Growth EIS opportunity centred around innovative technologies
- Co-investment strategy with proven business angels
- Emerging record of exits
- Marries innovation and commercial opportunity
- Minimum £20,000
Read important documents and apply
Based in Edinburgh, Par Equity provides both intellectual and financial capital to early stage companies. Par made its first investment in March 2009 and launched the EIS fund in late 2012. The fund was primarily formed to invest alongside the Par Syndicate.
Par Equity sources deals for successful entrepreneurs or high flyers who are looking to reinvest the proceeds of a business sale or their earnings. These Business Angels make up the Par Syndicate, around 130 people. Broadly speaking half are entrepreneurs who have realised their businesses and the other half are professionals (e.g. high-ranking lawyers and accountants).
These angels are central to the investment process. On the one hand, they provide Par Equity with deal flow. For instance, if an entrepreneur or group of entrepreneurs come up with a new mobile app, they may approach a member of the syndicate who has previously had success in that area. The member in turn will pass the opportunity, alongside their views, on to Par Equity.
On the other hand, the Business Angels offer intellectual capital and skills Par Equity may not have in-house. The investment team has a great deal of experience but concede they will not have a firm handle on all the technologies they see. So, they will ask the Par Syndicate to validate the technology and market opportunity they are looking at.
Investments are made in companies which are largely generating revenue but are pre-profit at the point of investment. Par Equity tend to participate in investment rounds of at least £0.5 million. The fund is largely sector agnostic but will not participate in biotech or anything Par Equity deems to be morally dubious: the manufacture of armaments or weapons technology for instance.
Before considering an investment, Par Equity will ask two key questions. Firstly, does the idea or technology have a competitive advantage? Secondly, is there a buyer for it?
Geographically, they believe there is an arc of opportunity from Belfast through the North West of England up into Scotland. Businesses within the area operate from lower-cost properties, employ smart people for less and don’t succumb to the hype sometimes afforded to businesses in the South East.
Moreover, Par Equity, whilst focused on UK businesses, looks for companies with the potential to go global. They argue you can easily do that outside London.
To take advantage of this opportunity, Par Equity uses a collaborative co-investment model.
It won’t invest unless Angels in the network are also investing. This provides an extra layer of due diligence and the Angel investments should help ensure investee companies don’t become lifestyle businesses.
Par Equity argues that if an investment manager simply doles out funding to ten businesses they will focus predominantly on only one or two. They may not intend to but it is only natural. Some will do better than others.
By having an Angel invested there is a party with skin in the game. The Angel is very unlikely to have participated in all the deals. So, their investment should be one of their main priorities. As such, they will monitor and tend to it closely.
Additionally, support for investee companies will be given by Par Equity’s Advisory Panel. This is formed from the Angel network and comprises individuals interested in taking a more active role in supporting the businesses. Investee companies need different levels of support from different areas at various times and access to a flexible pool of expertise should be a benefit.
Typically, Par Equity will appoint someone to the board of investee companies. Usually this is an Angel who has invested but may be a member of staff.
Investors in this EIS can expect exposure to six or seven underlying companies. One of the six or seven underlying companies is likely to be pre-revenue or at an even earlier stage. If this business goes well, it can really fly. If it doesn’t investors should expect a total loss (ignoring the tax reliefs). From a portfolio construction perspective, this can be a sensible approach. Furthermore, no new investee company will account for more than 25% of an investor’s portfolio.
The nature of businesses in the portfolio mean the first round of funding is unlikely to be the last. Future rounds may dilute existing investments. Par Equity aims to allow existing investors to participate directly in follow on funding, outside the fund.
Exits will be sought through trade sales. It’s hard to put a timeframe on exits given the type of investee businesses in the portfolio. Anywhere between three to eight years is likely so investors should be prepared for long term.
The chart below shows the net return of investing £100 in the Par Syndicate EIS Fund in the tax year indicated. For example, £100 invested in 2015/16 would now be valued at £191.10 based on Par Equity's own valuation: note past performance is not a guide to the future and these kind of investments can be illiquid and hard to sell and value.
|Subscription date||Dec 2014||Dec 2015||Dec 2016||Dec 2017||Dec 2018|
|2014/15 (Sep 14)||100||149.10||157.48||191.89||186.57|
|2015/16 (Sep 15)||n/a||100||136.41||136.42||191.10|
|2016/17 (Sep 16)||n/a||n/a||100||110.79||129.46|
|2017/18 (Sep 17)||n/a||n/a||n/a||100||103.18|
|2018/19 (Sep 18)||n/a||n/a||n/a||n/a||100|
There is an emerging track record of exits, although remember past performance is not a guide to the future.
In May 2018 Par Syndicate (not the EIS) exited ICS Learn. ICS Learn (International Correspondence Schools) is a Glasgow-based distance learning business. Par Syndicate invested in late 2012. At that time, despite being a long-established specialist in its sector, ICS Learn had an uncertain future. After half a decade of refocusing, it is a fully-fledged online education provider and a trailblazer in virtual learning environments. One of its courses, centered on personal fitness, was the first in the world to allow students to complete their qualification exclusively through video submissions of their work.
Par Syndicate EIS had its first exit in June 2016 – PathXL. PathXL provides cancer detection software. Its software, TissueMark, allows pathology labs to use digital scanners and identify tumours in a growing number of cancer types. Par Syndicate EIS fund invested in November 2012 and investors received a cash on cash return of 2.7x when PathXL was acquired by Philips in June 2016. Remember, past performance is not a guide to the future.
As with any high risk EIS investment, not all investments will work out as planned. One such failure was an investment in a company called Shaw Water, a technology that automatically tested water for impurities. It was an innovative product but didn’t work as planned. As a consequence, Par Equity is now much more cautious of novel products. Before investing they will look for strong evidence it is attractive to purchasers and use revenues, however small, as a proxy for working out if something does what it says on the tin.
Investors should be aware they will only have exposure to new businesses, not the current portfolio.
Risks – important
This, like all investments available through Wealth Club, is only for experienced investors happy to make their own investment decisions without advice.
EIS / SEIS investments are high-risk so should only form part of a balanced portfolio and you should not invest money you cannot afford to lose. They also tend to be illiquid and hard to sell and value. Before you invest, please carefully read the Risks and Commitments and the offer documents to ensure you fully understand the risks.
Tax rules can change and benefits depend on circumstances.
This EIS / SEIS fund invests in early-stage businesses which are more likely to fail than larger ones. So you should expect a number of failures in the portfolio.
Fees and charges
A summary of the fees and charges is shown below. Please see the provider's documents for more details.
|Full initial charge||1%|
|Wealth Club initial saving||0%|
|Net initial charge through Wealth Club||1%|
|Annual charge (4 years taken up front)||0.75%|
More detail on the charges
Par Equity’s approach to technology investing is refreshing, in our view. By focusing on the commercial viability of a technology and following a strict investment process, with the aid of their network, Par Equity appears to offer investors a sensible approach to technology investing.
Read important documents and apply
Wealth Club aims to make it easier for experienced investors to find information on – and apply for – tax-efficient investments. You should base your investment decision on the provider's documents and ensure you have read and fully understand them before investing. This review is a marketing communication. It is not advice or a personal or research recommendation to buy the investment mentioned. It does not satisfy legal requirements promoting investment research independence and is thus not subject to prohibitions on dealing ahead of its dissemination.
- Target return
- Funds raised / sought
- £2.4 million raised
- Minimum investment
- 26 Apr 2019 for next allotment